nach oben

Erschienen in:

01.02.2014 | RESEARCH ARTICLE

The Thr241Met polymorphism in the XRCC3 gene is associated with increased risk of cancer in Chinese mainland populations

Erschienen in: Tumor Biology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

The Thr241Met polymorphism in XRCC3 gene may affect the DNA repair pathways and be associated with the risk of cancer. However, the results of previous studies are inconsistent in Chinese mainland populations. The objective of this study is to investigate the association between the Thr241Met polymorphism in XRCC3 gene and risk of cancer for the Chinese Mainland populations by meta-analysis. We searched PubMed database, Embase database, CNKI database, and Wanfang database, and the last search was updated on July 24, 2013. Statistical analysis was performed using RevMan4.2 and Stata10.0 software. Finally, a total of 23 case–control studies in 23 articles were included. The results suggested a significant association between the Thr241Met polymorphism in XRCC3 gene and cancer risk in Chinese mainland populations (Met/Met + Thr/Met vs. Thr/Thr: OR = 1.25, 95 % CI = 1.02–1.54, P = 0.04). In the subgroup analyses by cancer types, significant associations were found in cervical cancer and nasopharyngeal cancer. The current meta-analysis suggested that the Thr241Met polymorphism in the XRCC3 gene may be a risk factor for cancer in Chinese mainland populations. In the future, more case–control studies are needed to validate these results.

Zhao P, Dai M, Chen W, Li N. Cancer trends in China. Jpn J Clin Oncol. 2010;40:281–5.PubMedCrossRef

Curtin NJ. DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer. 2012;12:801–17.PubMedCrossRef

Guo SJ, Li XB, Gao M, Li YQ, Song B, Niu WQ. The relationship between xrcc1 and xrcc3 gene polymorphisms and lung cancer risk in northeastern Chinese. PLoS ONE. 2013;8:e56213.PubMedCentralPubMedCrossRef

Han XC, Xing QZ, Li Y, Sun FJ, Ji HH, Pan HZ, et al. Study on the DNA repair gene xrcc1 and xrcc3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk. Hepato-Gastroenterol. 2012;59:2285–9.

He XH, Ye F, Zhang J, Cheng Q, Shen JJ, Chen HZ. Susceptibility of xrcc3, xpd, and xpg genetic variants to cervical carcinoma. Pathobiology. 2008;75:356–63.PubMedCrossRef

Zhang YG, Li XB, Zhang J, Huang J, He C, Tian C, et al. The i/d polymorphism of angiotensin-converting enzyme gene and asthma risk: a meta-analysis. Allergy. 2011;66:197–205.PubMedCrossRef

Huang M. The association between polymorphisms in xrcc3 gene, environment and lung cancer,Thesis: Fujian Medical University, 2010.

Huang XX. Polymorphisms of xpa and xrcc3, environmental agent and susceptibilities to esophageal, cardia and non-cardia gastric cancer. Thesis: Fujian Medical University, 2007.

Jin MJ, Chen K, Song L, Fan CH, Chen Q, Zhu YM, et al. The association of the DNA repair gene xrcc3 thr241met polymorphism with susceptibility to colorectal cancer in a Chinese population. Cancer Genet Cytogenet. 2005;163:38–43.PubMedCrossRef

10.

Liang G. The association between DNA repair genes and carcinogens metabolic gene single nucleotide polymorphism and lung cancer genetic susceptibility. Thesis: Chinese Peking Union Medical College, 2004.

11.

Liu L, Yang L, Mi YC, Wang JX, Li JY, Zhang Y, et al. Rad51 and xrcc3 polymorphisms: impact on the risk and treatment outcomes of de novo inv (16) or t (16; 16)/cbfβ– myh11(+) acute myeloid leukemia. Leuk Res. 2011;35:1020–6.PubMedCrossRef

12.

Long XD, Ma Y, Qu DY, Liu YG, Huang ZQ, Huang YZ, et al. The polymorphism of xrcc3 codon 241 and afb1-related hepatocellular carcinoma in Guangxi population, China. Ann Epidemiol. 2008;18:572–8.PubMedCrossRef

13.

Qian BY, Zhang H, Zhang LN, Zhou XY, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. 2011;73:138–46.PubMedCrossRef

14.

Ritchey JD, Huang WY, Chokkalingam AP, Gao YT, Deng J, Levine P, et al. Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer Epidemiol Biomark Prev. 2005;14:1703–9.CrossRef

15.

Shen HB, Wang XR, Hu ZB, Zhang ZD, Xu YC, Hu X, et al. Polymorphisms of DNA repair gene xrcc3 thr241met and risk of gastric cancer in a Chinese population. Cancer Letters. 2004;206:51–8.PubMedCrossRef

16.

Wen SX. Relationship between polymorphisms in DNA base excision repair gene and risk of laryngeal and hypopharyngeal cancer, Thesis, Chinese Peking Union Medical College, 2006.

17.

Xia WJ, Zhang YM, Su D, Shi F. Association of single nucleotide polymorphisms of DNA repair gene xrcc3-241 with non-small cell lung cancer (Chinese). Zhe Jiang Yi Xue. 2008;30:1291–3.

18.

Xiao HY, Wu WQ, Bao XM, Xie HY. The association between polymorphism in the xrcc3 gene and the risk of cervical cancer (Chinese). Jin Lin Yi Xue. 2010;31:2371–2.

19.

Yang QX, Chen K, Han QH. Relationship between polymorphisms in DNA repair gene xrcc1 and xrcc3 and the risk of bladder cancer (Chinese). Zhong Guo Wu Zhen Xue Za Zhi. 2009;9:8383–4.

20.

Yang ZH, Du B, Wei YS, Zhang JH, Zhou B, Liang WB, et al. Genetic polymorphisms of the DNA repair gene and risk of nasopharyngeal carcinoma. DNA Cell Biol. 2007;26:491–6.PubMedCrossRef

21.

Zhang JW, Meng XL. Polymorphisms of DNA repair gene xrcc3 and susceptibility of colon carcinoma (Chinese). An Hui Yi Ke Da Xue Xue Bao. 2011;46:1172–5.

22.

Zhang MD, Huang WY, Andreotti G, Gao YT, Rashid A, Chen JB, et al. Variants of DNA repair genes and the risk of biliary tract cancers and stones: a population-based study in china. Cancer Epidemiol Biomark Prev. 2008;17:2123–7.CrossRef

23.

Zhang YM, Ye EJ, Wang HM, Shi YS, Cheng L. The association between single nucleotide polymorphisms of xrcc3 gene thr241met (rs861539) site and nasopharyngeal carcinoma susceptibility (Chinese). Shi Yong Yi Xue Za Zhi. 2012;28:2684–6.

24.

Zhao P, Zou P, Zhao L, Yan W, Kang C, Jiang T, et al. Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility. BMC Cancer. 2013;13:234.PubMedCentralPubMedCrossRef

25.

Zhou KK, Liu YH, Zhang HS, Liu HL, Fan WW, Zhong Y, et al. Xrcc3 haplotypes and risk of gliomas in a Chinese population: a hospital–based case–control study. Int J Cancer. 2009;124:2948–53.PubMedCrossRef

26.

Zhu X, Zhong ZH, Zhang XZ, Zhao XK, Xu R, Ren WG, et al. DNA repair gene xrcc3 t241m polymorphism and bladder cancer risk in a Chinese population. Gene Test Mol Biomark. 2012;16:640–3.CrossRef

Titel: The Thr241Met polymorphism in the XRCC3 gene is associated with increased risk of cancer in Chinese mainland populations
Publikationsdatum: 01.02.2014
Erschienen in: Tumor Biology / Ausgabe 2/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-013-1187-z

Springer Medizin

The Thr241Met polymorphism in the XRCC3 gene is associated with increased risk of cancer in Chinese mainland populations

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2014

Applicability of gene expression profile of childhood acute lymphoblastic leukemia at diagnosis and at the end of the induction phase of chemotherapy at a cancer hospital in the state of Goiás (Brazil)

Inhibition of autophagy induced by TSA sensitizes colon cancer cell to radiation

Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis

Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case–control studies

Murine double minute 2 rs2279744 polymorphism and hepatocellular carcinoma risk in East Asians: a meta-analysis

Bufalin inhibits the differentiation and proliferation of human osteosarcoma cell line hMG63-derived cancer stem cells

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie